• Local news

    Expedite action on local vaccine production – Akufo-Addo to National Vaccine Institute

    President Akufo-Addo has charged the National Vaccine Institute (NVI) to work to bring to fruition the vision of developing and manufacturing vaccines locally. 

    He told the Board that Ghana must build the capacity to manufacture vaccines to reduce dependence on unreliable sources, as was witnessed during the height of the Covid-19 pandemic. 

    The country can no longer be pawns in the global vaccine market. They must achieve self-sufficiency in vaccine production to meet future national, regional and continental needs for health security.  

    The President made the call on Wednesday, May 10 when he inaugurated the new 13-member Governing Board at a short ceremony at the Jubilee House, Accra. 

    Expedite action on local vaccine production - Akufo-Addo to National Vaccine Institute
    Chaired by Dr Anarfi Asamoah-Baah, Head of the Presidential Task Force on COVID-19, the Board will facilitate the coordination of all vaccine-related activities in Ghana. 

    The other members of the board are Prof. William Kwabena Ampofo, CEO of NVI, Dr Baffour-Awuah, representative of the Ministry of Health, Mr Mustapha Tawiah Kumah, representative of the Ministry of Trade and Industry, Dr Daniel Gyingiri Achel, representative of the Ministry of Environment, Science, Technology and Innovation, and Ms. Fredrica Sala Illiasu, representative of the Office of the Attorney-General and Ministry of Justice. 

    Expedite action on local vaccine production - Akufo-Addo to National Vaccine Institute
    The rest are, Dr Delese Darko, representative of the Food and Drugs Authority, Professor Alex Dodoo, representative of Ghana Standards Authority, Dr Patrick Kuma-Aboagye, representative of the Ghana Health Service, Mr Kofi Nsiah-Poku, representative of the President of the Pharmaceutical Manufacturers Association of Ghana, Professor Kofi Opoku Nti, President of the Ghana Academy of Arts and Sciences, Professor Gordon A. Awandare and Prof. Rita Akosua Dickson, both nominees of the Minister of Health. 

    President Akufo-Addo recalled Ghana’s struggle to secure vaccines on the international market when the COVID-19 pandemic struck the country, saying, “We cannot continue on this unsustainable path.” 

    He said the global vaccine politics encouraged his government to initiate measures to produce critical vaccines locally and asked the Board to work to meet the expectation of Ghanaians to save the country from global vaccine nationalism and geopolitics. 

    He assured the NVI board of the government’s support and urged the body to pursue stakeholder consultation in the fulfilment of its mandate. 

    Expedite action on local vaccine production - Akufo-Addo to National Vaccine Institute
    Dr Asamoah-Baah assured the President that the board would work to ensure the efficient implementation of the key functions of the institute. 

    “We recognise that our remit is a subset of the broader national agenda, as a nation we still have challenges with vaccine literacy, vaccine hesitancy, vaccine shortage and vaccine financing. 

    “We pledge to collaborate with the agencies and institutions that have prime responsibility for these areas so that not only do we do our work, but we will also help to advance the vaccine agenda,” he said. 

    The President later commissioned the new ultra-modern office complex for the NVI at Cantonments, Accra, and charged the institute to maintain the facility. 

    The NVI, established by an Act of Parliament coordinate vaccine research, development and manufacturing in Ghana. 

    President Akufo-Addo told the gathering, after commissioning the facility that Ghana’s short-term goal was to fill, finish, and package COVID-19, malaria and tuberculosis vaccines within two years. 

    In the medium term, he noted that the target is to continue to establish more domestic plants in Ghana in five years to meet the World Health Organisation standard. 

    The government’s long-term plan is to produce a candidate vaccine using innovative technology in ten years. 

    Leave A Comment